BIOMAT Database Logo BIOMAT Database Logo

[Effective combined therapy of selective beta 1-adrenergic antagonist and selective beta 2-adrenergic agonist in a patient with bronchial asthma and hypertrophic cardiomyopathy]. 1984

T Yukawa, and T Numao, and S Motojima, and T Fukuda, and R Ikemori, and S Makino, and T Shimizu, and T Hayashi

UI MeSH Term Description Entries
D008790 Metoprolol A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS. Beloc-Duriles,Betaloc,Betaloc-Astra,Betalok,CGP-2175,H 93-26,Lopressor,Metoprolol CR-XL,Metoprolol Succinate,Metoprolol Tartrate,Seloken,Spesicor,Spesikor,Toprol,Toprol-XL,Beloc Duriles,Betaloc Astra,CGP 2175,CGP2175,H 93 26,H 9326,Metoprolol CR XL,Toprol XL
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002312 Cardiomyopathy, Hypertrophic A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). Cardiomyopathy, Hypertrophic Obstructive,Cardiomyopathies, Hypertrophic,Cardiomyopathies, Hypertrophic Obstructive,Hypertrophic Cardiomyopathies,Hypertrophic Cardiomyopathy,Hypertrophic Obstructive Cardiomyopathies,Hypertrophic Obstructive Cardiomyopathy,Obstructive Cardiomyopathies, Hypertrophic,Obstructive Cardiomyopathy, Hypertrophic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000420 Albuterol A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. Salbutamol,2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol,Albuterol Sulfate,Proventil,Sultanol,Ventolin
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

T Yukawa, and T Numao, and S Motojima, and T Fukuda, and R Ikemori, and S Makino, and T Shimizu, and T Hayashi
Cardio-selective beta-adrenergic therapy in a patient with asthma and hypertrophic obstructive cardiomyopathy.
July 1981, Chest,
T Yukawa, and T Numao, and S Motojima, and T Fukuda, and R Ikemori, and S Makino, and T Shimizu, and T Hayashi
Comparison between an alpha-adrenergic antagonist and a beta 2-adrenergic agonist in bronchial asthma.
April 1983, Chest,
T Yukawa, and T Numao, and S Motojima, and T Fukuda, and R Ikemori, and S Makino, and T Shimizu, and T Hayashi
[The effects of combined beta(1) adrenergic receptor antagonist and beta(2) adrenergic receptor agonist therapy on cardiac function and myocardial apoptosis in heart failure rats].
July 2007, Zhonghua xin xue guan bing za zhi,
T Yukawa, and T Numao, and S Motojima, and T Fukuda, and R Ikemori, and S Makino, and T Shimizu, and T Hayashi
Dilevalol: a selective beta-2 adrenergic agonist vasodilator with beta adrenergic blocking activity.
December 1989, Journal of clinical pharmacology,
T Yukawa, and T Numao, and S Motojima, and T Fukuda, and R Ikemori, and S Makino, and T Shimizu, and T Hayashi
The effects of a beta-2 selective adrenergic agonist and a beta-nonselective antagonist on theophylline clearance.
July 1987, Journal of clinical pharmacology,
T Yukawa, and T Numao, and S Motojima, and T Fukuda, and R Ikemori, and S Makino, and T Shimizu, and T Hayashi
Inhaling beta(2)-agonist with heliox-driven in bronchial asthma.
July 2003, Chinese medical journal,
T Yukawa, and T Numao, and S Motojima, and T Fukuda, and R Ikemori, and S Makino, and T Shimizu, and T Hayashi
Combined cholinergic antagonist and beta 2-adrenoceptor agonist bronchodilator therapy by inhalation.
October 1979, Australian and New Zealand journal of medicine,
T Yukawa, and T Numao, and S Motojima, and T Fukuda, and R Ikemori, and S Makino, and T Shimizu, and T Hayashi
[New viewpoints on therapy with beta-2-agonist-type bronchodilators and corticosteroids in bronchial asthma].
January 1992, Pneumoftiziologia : revista Societatii Romane de Pneumoftiziologie,
T Yukawa, and T Numao, and S Motojima, and T Fukuda, and R Ikemori, and S Makino, and T Shimizu, and T Hayashi
Beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy.
April 1966, British medical journal,
T Yukawa, and T Numao, and S Motojima, and T Fukuda, and R Ikemori, and S Makino, and T Shimizu, and T Hayashi
Beta-adrenergic blockade in patients with hypertrophic obstructive cardiomyopathy.
January 1967, American heart journal,
Copied contents to your clipboard!